Our results showed that the expression level of CBS, CD44, AKR1C2, CHAC1, and SLC7A11was positively associated with the progression of ccRCC, while contrary results appeared in HMOX1 and HMGCR. The gene discussed is AKR1C2; the disease is nonpapillary renal cell carcinoma.